600436.SS vs XLV — which is stronger right now?
Same dated snapshot (2026-09-01): 600436.SS quality —/100 vs XLV 100/100; engine LONG vs LONG. The comparison below is computed, dated, and auditable — not an opinion.
| Snapshot | 2026-09-01 · source: tencent | |
|---|---|---|
| 600436.SS (Pien Tze Huang) | XLV (Health Care) | |
| Market / sector | ashare · TCM Pharma | us · ETF |
| Price | ¥126.15 | $173.54 |
| Quality score | —/100 | 100/100 |
| Engine signal | LONG · 31 bars · uPnL -0.5% | LONG · 65 bars · uPnL +15.8% |
| Total return | -7.8% | +16.5% |
Thesis-break template (TCM Pharma)
flagship drug losing exclusivity; pivotal trial failure; pricing-policy shifts; payer consolidation
Cite this page
Balance Labs Research Desk (2026-09-01). "600436.SS vs XLV — which is stronger right now?." balancelabs.app · https://balancelabs.app/stocks/compare/600436.ss-vs-xlv · CC BY 4.0
Ask anything
30 free credits monthly · no card required · research support, not advice
← compare hub · snapshot 2026-09-01 · not investment advice